tci Medicare Compliance & Reimbursement - 2005 Issue 36

Hospitals: Don't Forget About Pending OPPS Changes

Pass-through payments possible for certain codes.The bulk of the changes to hospital outpatient prospective payment system billing procedures and payment policies will affect facility claims for drugs and biologicals.Effective Oct. 1, 2005, the Centers for Medicare and Medicaid Services will grant "pass-through" status to C9225 (Injection, fluocinolone acetonide intravitreal implant, per 0.59 mg) and C9226 (Injection, ziconotide for intrathecal infusion, per 5 mcg), the agency announced in a Sept. 2 Medlearn Matters article. Other changes under the October OPPS update include:• The pass-through status effective date for J8501 (Aprepitant, oral, 5 mg) is April 4...

To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.


Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4200 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
Access to this feature is available in the following products:
  • tci Medicare Compliance & Reimbursement +Archives

demo
request yours today
subscribe
start today
newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.